Monitoring and Management of Patients on Therapy for Chronic Hepatitis B
This answer is incorrect. According to AASLD guidelines, all patients on therapy for HBV should have a liver panel measured every 3 months and HBV DNA levels quantified every 3 to 6 months. The frequency of HBV DNA monitoring is to assure an initial response to therapy and that any antiviral resistance is picked up early.
Choose another answer: